AKT1
AKT1 is a gene that plays a critical role in various cellular processes, including metabolism, cell proliferation, cell survival, growth, and angiogenesis. It is part of the PI3K/AKT/mTOR pathway, a signaling pathway that is vital for cellular growth and survival. This pathway is often dysregulated in various types of cancer, making AKT1 a significant focus of oncology research.
Function[edit]
AKT1 encodes a serine/threonine protein kinase that is activated by phosphorylation in response to various growth factors and hormones. Once activated, AKT1 phosphorylates a wide range of substrates involved in the regulation of cell survival, cell cycle progression, and apoptosis (programmed cell death). This kinase plays a key role in preventing apoptosis induced by cellular stress or damage, thereby promoting cell survival and growth.
Clinical Significance[edit]
The AKT1 gene is implicated in several human diseases, most notably in cancer. Mutations and amplifications of AKT1 have been identified in a variety of cancers, including breast cancer, ovarian cancer, and lung cancer. These alterations lead to the hyperactivation of the AKT1 kinase, promoting uncontrolled cell growth and survival, which are hallmarks of cancer. As such, AKT1 is a target for cancer therapy, with several inhibitors being developed to block its activity.
In addition to cancer, AKT1 mutations have been associated with other conditions, such as the Proteus syndrome, a rare disorder characterized by overgrowth of tissues and organs. The precise role of AKT1 in this condition is still under investigation.
AKT1 and Cancer Therapy[edit]
Given its central role in cell survival and growth, AKT1 is a promising target for cancer therapy. Inhibitors of AKT1 are being developed and tested in clinical trials, with the aim of blocking the aberrant signaling pathway in cancer cells. These inhibitors have the potential to suppress tumor growth and enhance the effectiveness of existing cancer treatments.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian